Related Experiment Video
Updated: Aug 31, 2025
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS)
Matthew Alonzo1, Javier Contreras1, Shiqiao Ye1
1Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; The Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Insights
Researchers created a patient-specific induced pluripotent stem cell (iPSC) line for studying hypoplastic left heart syndrome (HLHS). This HLHS iPSC line offers a valuable tool for understanding the cellular basis of this severe congenital heart defect.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Developmental Biology
Background:
- Hypoplastic left heart syndrome (HLHS) is a critical congenital heart defect.
- It involves underdeveloped left-sided heart structures, including the left ventricle, aorta, and mitral valve.
Purpose of the Study:
- To generate a patient-specific induced pluripotent stem cell (iPSC) line from an HLHS patient.
- To characterize the generated iPSC line for pluripotency and differentiation potential.
- To establish a cellular model for studying HLHS etiologies.
Main Methods:
- Generated iPSCs from peripheral blood mononuclear cells of a male HLHS patient.
- Utilized Sendai virus-mediated transfection of four Yamanaka factors.
- Assessed iPSC morphology, pluripotency marker expression, karyotype, and differentiation capacity.
Main Results:
- Successfully generated a stable iPSC line from an HLHS patient.
- The iPSC line displayed normal morphology and expressed key pluripotency markers.
- Confirmed a normal karyotype and the ability of iPSCs to differentiate into three germ layers.
Conclusions:
- The generated HLHS iPSC line is a valuable resource.
- This iPSC line can be utilized for investigating the cellular and developmental causes of HLHS.
- Enables future research into novel therapeutic strategies for congenital heart defects.
Abstract:
Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect characterized by underdeveloped structures on the left side of the heart, including hypoplasia of the left ventricle and stenosis or atresia of the aortic and mitral valves. Here, we generated an iPSC line from the peripheral blood mononuclear cells of a male patient with HLHS through Sendai virus-mediated transfection of 4 Yamanaka factors. This iPSC line exhibited normal morphology, expressed pluripotency markers, had a normal karyotype, and could differentiate into cells of three germ layers. This iPSC line can be used for studying cellular and developmental etiologies of HLHS.
